Aptus Pharma (BOM:544529) Scaled Net Operating Assets: 0.75 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544529 Aptus Pharma Ltd BOM:544529
18 GF Score
Price ₹269.50
! 6 Warning Signs
View Full Analysis

What is Aptus Pharma Scaled Net Operating Assets?

Aptus Pharma BOM:544529 +3.63% 18 Scaled Net Operating Assets is 0.75 as of Mar. 2026. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aptus Pharma's operating assets for the quarter that ended in Mar. 2026 was ₹425.1 Mil. Aptus Pharma's operating liabilities for the quarter that ended in Mar. 2026 was ₹130.1 Mil. Aptus Pharma's Total Assets for the quarter that ended in Sep. 2025 was ₹395.9 Mil. Therefore, Aptus Pharma's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.75.


Aptus Pharma Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Aptus Pharma's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aptus Pharma Scaled Net Operating Assets Chart

Aptus Pharma Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Scaled Net Operating Assets
0.43 0.99 1.21 1.35

Aptus Pharma Semi-Annual Data
Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial 0.99 0.00 0.00 0.71 0.75

BOM:544529 vs MCK, COR, CAH: Scaled Net Operating Assets Comparison

For the Medical Distribution subindustry, Aptus Pharma's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptus Pharma Scaled Net Operating Assets vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Aptus Pharma's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Aptus Pharma's Scaled Net Operating Assets falls into.


BOM:544529
18GF Score
Aptus Pharma Ltd BOM:544529
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aptus Pharma Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aptus Pharma's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2026 )
=(Operating Assets (A: Mar. 2026 )-Operating Liabilities (A: Mar. 2026 ))/Total Assets (A: Mar. 2025 )
=(425.077-130.07)/219.199
=1.35

where

Operating Assets(A: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=435.348 - 10.271
=425.077

Operating Liabilities(A: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=201.886 - 5.216 - 66.6
=130.07

Aptus Pharma's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Sep. 2025 )
=(425.077-130.07)/395.873
=0.75

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=435.348 - 10.271
=425.077

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=201.886 - 5.216 - 66.6
=130.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.75 mean?
Aptus Pharma (BOM:544529) has a Scaled Net Operating Assets of 0.75 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Aptus Pharma and its competitors.
Is Aptus Pharma's Scaled Net Operating Assets too high?
Aptus Pharma's current Scaled Net Operating Assets is 0.75. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's Scaled Net Operating Assets compare to MCK and COR?
Aptus Pharma's Scaled Net Operating Assets of 0.75 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Distribution company?
A good Scaled Net Operating Assets depends on the Medical Distribution industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Aptus Pharma and its competitors. Aptus Pharma's current Scaled Net Operating Assets is 0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current Scaled Net Operating Assets of 0.75. The current Scaled Net Operating Assets is 0.75. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current Scaled Net Operating Assets is 0.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aptus Pharma Business Description

Address Narayan Nagar, Kalawad Road, SHREE Building, 1st Floor, Opp Satyasai Heart Hospital, Sau Uni Area, Rajkot, GJ, IND, 360005
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score

Get the complete analysis for BOM:544529

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹269.50
Price